Related Experiment Video
Updated: Jun 14, 2026

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
Published on: April 3, 2026
Novel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study
M Fareed K Suri1, Kazumasa Yamagishi, Nena Aleksic
1Department of Neurology, School of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Insights
Higher levels of factor XI, a clotting protein, are linked to an increased risk of ischemic stroke. This finding may help identify individuals at greater risk for stroke.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Epidemiology
Background:
- The association between hemostatic factor levels and cerebral infarction (ischemic stroke) is not fully understood.
- Several under-studied hemostatic factors require investigation in relation to stroke risk.
Purpose of the Study:
- To investigate the association of specific hemostatic factor levels with the incidence of ischemic stroke.
- To identify potential biomarkers for predicting ischemic stroke risk in a population-based cohort.
Main Methods:
- Utilized a case-cohort design within the Atherosclerosis Risk in Communities (ARIC) study (n=15,792).
- Measured levels of hemostatic factors (II, V, IX, X, XI, XII, plasminogen, alpha(2)-antiplasmin) in plasma samples.
- Employed multivariate proportional hazard regression analyses to assess associations with incident ischemic stroke over a median of 7.5 years.
Main Results:
- Elevated levels of factor XI, factor IX, and alpha(2)-antiplasmin were initially associated with increased ischemic stroke risk (highest vs. lowest quartiles).
- After multivariate adjustment, only higher factor XI levels remained significantly associated with an increased risk of ischemic stroke (HR 1.50, 95% CI 1.10-2.05).
Conclusions:
- Increased levels of factor XI are associated with a higher risk of developing ischemic stroke.
- Factor XI may serve as a valuable biomarker for identifying individuals at elevated risk of ischemic stroke.
Background And Objective:
The role of hemostatic factor levels in cerebral infarction remains uncertain. We studied the association of levels of several under-studied hemostatic factors with ischemic stroke in a population-based cohort.
Methods:
The Atherosclerosis Risk in Communities (ARIC) study includes 15,792 individuals aged 45-54 years at intake. Hemostatic factors II, V, IX, X, XI, XII, plasminogen and alpha(2)-antiplasmin were measured on frozen citrate plasma samples from 1990 to 1992. A case-cohort design was used, including all incident ischemic strokes (n = 89) over a median of 7.5 years and a stratified cohort random sample (n = 412). To determine the association of hemostatic factors with incident ischemic stroke, we computed hazard ratios (HRs) using multivariate proportional hazard regression analyses adjusted for demographic and other cardiovascular risk factors.
Results:
The cohort random sample had a mean age (SD) of 56.9 (5.4) years and 42% were men. The age-, sex- and race-adjusted HRs for highest versus lowest quartiles were: factor XI (2.74, 95% CI 1.42-5.29), factor IX (1.92, 95% CI 0.99-3.73), and alpha(2)-antiplasmin (2.24, 95% CI 1.16-4.33). Correspondingly, the HRs of ischemic stroke per SD increment of factors XI, IX, and alpha(2)-antiplasmin were 1.64, 1.46 and 1.52, respectively (all p < 0.05). After multivariate adjustment including other clinical variables, the standardized HR remained significant for factor XI (1.50, 95% CI 1.10-2.05), but no other factor.
Conclusion:
A greater level of factor XI was associated with an increased risk of ischemic stroke. Higher factor XI levels might help identify patients at elevated ischemic stroke risk.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Atherosclerosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Ischemic Stroke l: Introduction